Hanmi Pharmaceutical Company Limited
Registry sponsor category
Industry
- Company name
- Hanmi Pharmaceutical Company Limited
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Website
- http://www.hanmi.co.kr
- Hanmi Pharmaceutical co., ltd.
- Hanmi Pharmaceutical Company Limited
- Publicly traded (proxy)
- No
- Listing at source
- Listed
- Wikidata ID
- Q17095096
Related records
Trials (213)
- A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin
- A Bioequivalence Study Comparing HIP0901 Capsule With Lipidilsupra Tablet
- A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin
- A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan
- A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan
- A Drug Interaction Study of Montelukast and Levocetirizine
- A Drug-Drug Interaction Study of Ambroxol and Levodropropizine
- A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A
- A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470
- A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide)
- A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy Subjects
- A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects.
- A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
- A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension
- A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
- A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules
- A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HGP0412 and HIP1402 in Patients With BPH
- A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
- A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer
- A Pilot Study to Evaluate the Pharmacokinetics of Omega-3 Between Rosuvastatin and Omega-3 Coadministration and HCP1007